These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Possible approaches to a vaccine against Lassa fever. Clegg JC Trans R Soc Trop Med Hyg; 1984; 78(3):307-10. PubMed ID: 6464128 [No Abstract] [Full Text] [Related]
24. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Auperin DD; Esposito JJ; Lange JV; Bauer SP; Knight J; Sasso DR; McCormick JB Virus Res; 1988 Feb; 9(2-3):233-48. PubMed ID: 3354260 [TBL] [Abstract][Full Text] [Related]
25. Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. Lunkenheimer K; Hufert FT; Schmitz H J Clin Microbiol; 1990 Dec; 28(12):2689-92. PubMed ID: 2279999 [TBL] [Abstract][Full Text] [Related]
26. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. Walker DH; Johnson KM; Lange JV; Gardner JJ; Kiley MP; McCormick JB J Infect Dis; 1982 Sep; 146(3):360-8. PubMed ID: 6286795 [TBL] [Abstract][Full Text] [Related]
27. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys. Johnson KM; Elliott LH; Heymann DL J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084 [TBL] [Abstract][Full Text] [Related]
28. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Clegg JC; Lloyd G Lancet; 1987 Jul; 2(8552):186-8. PubMed ID: 2885642 [TBL] [Abstract][Full Text] [Related]
29. Pathologic and virologic study of fatal Lassa fever in man. Walker DH; McCormick JB; Johnson KM; Webb PA; Komba-Kono G; Elliott LH; Gardner JJ Am J Pathol; 1982 Jun; 107(3):349-56. PubMed ID: 7081389 [TBL] [Abstract][Full Text] [Related]
30. [The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus]. Vladyko AS; Bystrova SI; Malakhova IV; Kunitskaia LIa; Lemeshko NN; Kras'ko AG; Kozhich AT; Lukashevich IS Vopr Virusol; 1993; 38(1):30-4. PubMed ID: 7521097 [TBL] [Abstract][Full Text] [Related]
31. Standardization of a plaque assay for Lassa virus. Tomori O; Johnson KM; Kiley MP; Elliott LH J Med Virol; 1987 May; 22(1):77-89. PubMed ID: 3585290 [TBL] [Abstract][Full Text] [Related]
32. Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses. Lukashevich IS; Trofimov NM; Golubev VP; Maryankova RF Acta Virol; 1985 Dec; 29(6):455-60. PubMed ID: 2869655 [TBL] [Abstract][Full Text] [Related]
33. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Jahrling PB; Frame JD; Smith SB; Monson MH Trans R Soc Trop Med Hyg; 1985; 79(3):374-9. PubMed ID: 3898483 [TBL] [Abstract][Full Text] [Related]
34. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340 [TBL] [Abstract][Full Text] [Related]